Equine Ins antibody and antigen (recombinant protein)

Diagnostic anti-Equine Ins antibodies pairs and antigen for animal health (animal Equine/Horse Diabetes mellitus) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-Ins-Ag01Equine Ins$3090.00
GMP-EQU-Ins-Ab01Anti-Equine Ins mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-Ins-Ab02Anti-Equine Ins mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-Ins-Ab03Anti-Equine Ins human monoclonal antibody (mAb)$3090.00
GMP-EQU-Ins-Ab04Anti-Equine Ins human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-Ins-Ag01
Product NameEquine Ins
Target/BiomarkerEquine Ins
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine Ins antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Ins level test of animal Equine/Horse with Diabetes mellitus.
TagHis
Reconized/Reactive SpecicsEquine Ins
Product descriptionRecombinant Equine Ins protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-Ins-Ab01,GMP-EQU-Ins-Ab02
Target/BiomarkerEquine Ins
Product NameAnti-Equine Ins mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine Ins antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine Ins antibodies in Equine Ins level test of animal Equine/Horse with Diabetes mellitus.
Product descriptionAnti-Equine Ins mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine Ins antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-Ins-Ab03,GMP-EQU-Ins-Ab04
Target/BiomarkerEquine Ins
Product NameAnti-Equine Ins human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine Ins antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine Ins antibodies in Equine Ins level test of animal Equine/Horse with Diabetes mellitus.
Product descriptionAnti-Equine Ins mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine Insulin, an intricate peptide hormone comprising 51 amino acids, reigns supreme as a cornerstone of glucose regulation in horses. Produced and secreted by the beta cells nestled within the equine pancreas, it orchestrates a symphony of metabolic processes that dictate how horses utilize glucose for energy and storage.

    At its core, Equine Insulin serves as the conductor for cellular glucose uptake. Upon its release into circulation, it seeks out insulin receptors on the surfaces of target cells, notably those found in skeletal muscle and adipose tissue. This binding event sets in motion a finely tuned series of intracellular signaling pathways, culminating in the translocation of glucose transporters (GLUT4) to the cell membrane. These transporters act as the molecular gatekeepers that permit glucose entry into the cell, where it can be either converted into energy through glycolysis or stored as glycogen for future energy demands.

    The secretion of Equine Insulin is intricately linked to blood glucose levels. After a horse's meal, when glucose levels surge, beta cells respond by releasing insulin, effectively facilitating glucose uptake into cells and leading to a decline in blood glucose levels, restoring metabolic equilibrium. Conversely, during fasting or times of heightened energy demand, Equine Insulin secretion diminishes, allowing stored glucose to be mobilized and released into circulation to maintain vital glucose homeostasis.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.